Answers are grounded in this paper and cite their sources.
Analysis reveals how demographics, anti-diabetic drugs, and HbA1C levels affect cancer risk in type 2 diabetes patients.
Supplementary Figure S2: Marginal effects of the demographics, number of anti-diabetic drugs, renal function, and time-weighted mean of HbA1C with 95% CIs on new onset NPC and H&N cancer stratified by drug use in the matched cohort.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: